Looking Ahead to 2026: AI and the Future of Medtech

There’s no longer a debate about AI having an impact on healthcare. While we’re still in the early stages of the AI revolution, it’s now the rare clinician or patient who has not encountered an FDA-approved AI solution for some aspect of medical care, such as interpreting MRI images or analyzing electro-cardiograms. The problem is that for many of our clients, the customary use cases of identifying malignant cells or culling through piles of biodata don’t apply to them – either it’s not relevant to improving their products, or it’s simply not what their products do. For those clients, I would argue that the bigger potential for AI may actually be within their reach if they just look at AI a bit differently.

If you’d like to receive our 2026 MedTech Outlook White Paper, simply fill out the form to get your copy and become part of our community of forward-thinking MedTech innovators.